chorea

FDA Action Alert: Ipsen, Revance, Neurocrine and Regeneron
BioSpace
Mon, 08/14/23 - 11:29 am
FDA
Ipsen
Revance Therapeutics
Neurocrine
Regeneron
palovarotene
fibrodysplasia ossificans progressiva
Daxxify
cervical dystonia
Ingrezza
chorea
Huntington's disease
pozelimab
CHAPLE disease
Teva reports data from Huntington’s disease-linked chorea trial
Clinical Trials Arena
Wed, 10/19/22 - 10:54 am
Teva Pharmaceutical
Austedo
clinical trials
chorea
Huntington's disease
Teva clears submission hurdle for Huntington's drug
BioPharma Dive
Fri, 10/21/16 - 11:28 am
Teva Pharmaceutical
Huntington's disease
chorea
SD-809
FDA
FDA asks Teva Pharmaceutical for further study on Huntington drug
Yahoo/Reuters
Tue, 05/31/16 - 10:07 am
Teva Pharmaceutical
FDA
Huntington's disease
SD-809
chorea
Auspex Pharma's movement disorder drug succeeds late-stage trial
Yahoo/Reuters
Tue, 12/16/14 - 07:43 pm
Auspex Pharmaceuticals
chorea
Huntington's disease
SD-809
2 Biotechs Race To Treat Movement Disorders
Seeking Alpha
Fri, 06/27/14 - 09:23 am
movement disorders
tetrabenazine
Auspex Pharmaceuticals
Neurocrine Biosciences
tardive dyskinesia
chorea
Auspex Pharmaceuticals IPO More Auspicious Than It Sounds
Seeking Alpha
Mon, 02/3/14 - 10:44 am
Auspex Pharmaceuticals
IPOs
chorea
SD-809
Lundbeck makes multi-million investment
Hays Pharma, UK
Thu, 07/9/09 - 09:09 am
Lundbeck
Ovation
Xenazine
chorea
Huntington's disease
LifeHealth Limited